Evidence map›Paper›PMID 27626104›Full record

ArticleACS infectious diseases2016

Glycogen Synthase Kinase 3β Promotes the Endocytosis of Transferrin in the African Trypanosome.

Paul J Guyett, Shuangluo Xia, David C Swinney, Michael P Pollastri, Kojo Mensa-Wilmot

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Biomolecules · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Paul J GuyettDepartment of Cellular Biology, The Center for Tropical and Emerging Global Diseases, University of Georgia , 724 Biological Sciences Building, Athens, Georgia 30605, United States.
Shuangluo XiaInstitute for Rare and Neglected Disease Drug Discovery (IRND3) , 897 Independence Avenue #2C, Mountain View, California 94043, United States.
David C SwinneyInstitute for Rare and Neglected Disease Drug Discovery (IRND3) , 897 Independence Avenue #2C, Mountain View, California 94043, United States.
Michael P PollastriDepartment of Chemistry and Chemical Biology, Northeastern University , 417 Egan Building, 360 Huntington Avenue, Boston, Massachusetts 02115, United States.
Kojo Mensa-WilmotDepartment of Cellular Biology, The Center for Tropical and Emerging Global Diseases, University of Georgia , 724 Biological Sciences Building, Athens, Georgia 30605, United States.
Institute for Rare and Neglected Diseases Drug Discovery · USUniversity of Georgia · USNortheastern University · US

Funding

Development of HTS assay and screening paradigm to discover new kinase inhibitorsR01AI103476 · NIAID · INSTITUTE FOR RARE/NEGLECTED DISEASES · PI MENSA-WILMOT, KOJO A., SWINNEY, DAVID C · 2013 to 2015
$890k
Lead Optimization of Lapatinib Analogs for Human African TrypanosomiasisR56AI099476 · NIAID · UNIVERSITY OF GEORGIA · PI MENSA-WILMOT, KOJO A., POLLASTRI, MICHAEL P · 2014 to 2014
$672k
NIAID NIH HHS R01 AI103476NIAID NIH HHS R56 AI099476
6 · The paper itself

Abstract

Human parasite Trypanosoma brucei proliferates in the blood of its host, where it takes up iron via receptor-mediated endocytosis of transferrin (Tf). Mechanisms of Tf endocytosis in the trypanosome are not fully understood. Small molecule lapatinib inhibits Tf endocytosis in T. brucei and associates with protein kinase GSK3β (TbGSK3β). Therefore, we hypothesized that Tf endocytosis may be regulated by TbGSK3β, and we used three approaches (both genetic and small molecule) to test this possibility. First, the RNAi knock-down of TbGSK3β reduced Tf endocytosis selectively, without affecting the uptake of haptaglobin-hemoglobin (Hp-Hb) or bovine serum albumin (BSA). Second, the overexpression of TbGSK3β increased the Tf uptake. Third, small-molecule inhibitors of TbGSK3β, TWS119 (IC50 = 600 nM), and GW8510 (IC50 = 8 nM) reduced Tf endocytosis. Furthermore, TWS119, but not GW8510, selectively blocked Tf uptake. Thus, TWS119 phenocopies the selective endocytosis effects of a TbGSK3β knockdown. Two new inhibitors of TbGSK3β, LY2784544 (IC50 = 0.6 μM) and sorafenib (IC50 = 1.7 μM), were discovered in a focused screen: at low micromolar concentrations, they prevented Tf endocytosis as well as trypanosome proliferation (GI50's were 1.0 and 3.1 μM, respectively). These studies show that (a) TbGSK3β regulates Tf endocytosis, (b) TWS119 is a small-molecule tool for investigating the endocytosis of Tf,

Indexed as

EndocytosisGlycogen Synthase Kinase 3 betaHost-Parasite InteractionsHumansProtozoan ProteinsTransferrinTrypanosoma brucei bruceiTrypanosomiasis, AfricanGlycogen Synthase Kinase 3 betaProtozoan ProteinsTransferrindrug discoveryendocytosisglycogen synthase kinase 3βprotein kinasetrypanosome

Identifiers

PMID27626104
PMCPMC5025259
OpenAlexW2434703102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.